Vivian Glück1, Sonja Grobecker1, Leonid Tydykov1, Bernd Salzberger2, Thomas Glück3, Tanja Weidlich3, Manuela Bertok3, Christine Gottwald3, Jürgen J Wenzel1, André Gessner1,4, Barbara Schmidt1,4, David Peterhoff5. 1. Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany. 2. Department for Infection Control and Infectious Diseases, University Hospital Regensburg, Regensburg, Germany. 3. Kliniken Südostbayern, Traunstein, Germany. 4. Institute for Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany. 5. Institute for Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany. david.peterhoff@ur.de.
Abstract
OBJECTIVE: To follow serological immune responses of front-line healthcare workers after PCR-confirmed COVID-19 for a mean of 30 weeks, describe the time-course of SARS-CoV-2 spike protein-specific IgG, IgA and IgM levels and to identify associations of the immune response with symptoms, demographic parameters and severity of disease. METHODS: Anti-SARS-CoV-2 S protein-specific IgG, IgA and IgM antibodies were measured at three time points during the 30-week follow-up. COVID-19-specific symptoms were assessed with standardized questionnaires. RESULTS: 95% of the participants mounted an IgG response with only modest decline after week 12. IgG-type antibodies were still detectable in almost 90% of the subjects at 30 weeks. IgA and IgM responses were less robust and antibody titers decreased more rapidly. At 30 weeks, only 25% still had detectable IgA-type and none had IgM-type antibodies. Higher age and higher disease severity were independently associated with higher IgG antibody levels, albeit with wide variations. CONCLUSION: Serological immune responses after COVID-19 show considerable inter-individual variability, but show an association with increasing age and higher severity of disease. IgG-type anti-SARS-CoV-2 antibodies remain positive in 90% of the individuals 30 weeks after onset of symptoms.
OBJECTIVE: To follow serological immune responses of front-line healthcare workers after PCR-confirmed COVID-19 for a mean of 30 weeks, describe the time-course of SARS-CoV-2 spike protein-specific IgG, IgA and IgM levels and to identify associations of the immune response with symptoms, demographic parameters and severity of disease. METHODS: Anti-SARS-CoV-2 S protein-specific IgG, IgA and IgM antibodies were measured at three time points during the 30-week follow-up. COVID-19-specific symptoms were assessed with standardized questionnaires. RESULTS: 95% of the participants mounted an IgG response with only modest decline after week 12. IgG-type antibodies were still detectable in almost 90% of the subjects at 30 weeks. IgA and IgM responses were less robust and antibody titers decreased more rapidly. At 30 weeks, only 25% still had detectable IgA-type and none had IgM-type antibodies. Higher age and higher disease severity were independently associated with higher IgG antibody levels, albeit with wide variations. CONCLUSION: Serological immune responses after COVID-19 show considerable inter-individual variability, but show an association with increasing age and higher severity of disease. IgG-type anti-SARS-CoV-2 antibodies remain positive in 90% of the individuals 30 weeks after onset of symptoms.
Authors: Jennifer M Dan; Jose Mateus; Yu Kato; Kathryn M Hastie; Esther Dawen Yu; Caterina E Faliti; Alba Grifoni; Sydney I Ramirez; Sonya Haupt; April Frazier; Catherine Nakao; Vamseedhar Rayaprolu; Stephen A Rawlings; Bjoern Peters; Florian Krammer; Viviana Simon; Erica Ollmann Saphire; Davey M Smith; Daniela Weiskopf; Alessandro Sette; Shane Crotty Journal: Science Date: 2021-01-06 Impact factor: 47.728
Authors: Baweleta Isho; Kento T Abe; Michelle Zuo; Alainna J Jamal; Bhavisha Rathod; Jenny H Wang; Zhijie Li; Gary Chao; Olga L Rojas; Yeo Myong Bang; Annie Pu; Natasha Christie-Holmes; Christian Gervais; Derek Ceccarelli; Payman Samavarchi-Tehrani; Furkan Guvenc; Patrick Budylowski; Angel Li; Aimee Paterson; Feng Yun Yue; Lina M Marin; Lauren Caldwell; Jeffrey L Wrana; Karen Colwill; Frank Sicheri; Samira Mubareka; Scott D Gray-Owen; Steven J Drews; Walter L Siqueira; Miriam Barrios-Rodiles; Mario Ostrowski; James M Rini; Yves Durocher; Allison J McGeer; Jennifer L Gommerman; Anne-Claude Gingras Journal: Sci Immunol Date: 2020-10-08
Authors: Barbara Schmidt; Ralf Wagner; David Peterhoff; Vivian Glück; Matthias Vogel; Philipp Schuster; Anja Schütz; Philip Neubert; Veruschka Albert; Stefanie Frisch; Mara Kiessling; Philip Pervan; Maren Werner; Nicole Ritter; Leon Babl; Maria Deichner; Frank Hanses; Matthias Lubnow; Thomas Müller; Dirk Lunz; Florian Hitzenbichler; Franz Audebert; Viola Hähnel; Robert Offner; Martina Müller; Stephan Schmid; Ralph Burkhardt; Thomas Glück; Michael Koller; Hans Helmut Niller; Bernhard Graf; Bernd Salzberger; Jürgen J Wenzel; Jonathan Jantsch; André Gessner Journal: Infection Date: 2020-08-21 Impact factor: 7.455
Authors: Carolyn Rydyznski Moderbacher; Sydney I Ramirez; Jennifer M Dan; Alba Grifoni; Kathryn M Hastie; Daniela Weiskopf; Simon Belanger; Robert K Abbott; Christina Kim; Jinyong Choi; Yu Kato; Eleanor G Crotty; Cheryl Kim; Stephen A Rawlings; Jose Mateus; Long Ping Victor Tse; April Frazier; Ralph Baric; Bjoern Peters; Jason Greenbaum; Erica Ollmann Saphire; Davey M Smith; Alessandro Sette; Shane Crotty Journal: Cell Date: 2020-09-16 Impact factor: 66.850
Authors: Christoph Spinner; Jörg Janne Vehreschild; Carolin E M Jakob; Stefan Borgmann; Fazilet Duygu; Uta Behrends; Martin Hower; Uta Merle; Anette Friedrichs; Lukas Tometten; Frank Hanses; Norma Jung; Siegbert Rieg; Kai Wille; Beate Grüner; Hartwig Klinker; Nicole Gersbacher-Runge; Kerstin Hellwig; Lukas Eberwein; Sebastian Dolff; Dominic Rauschning; Michael von Bergwelt-Baildon; Julia Lanznaster; Richard Strauß; Janina Trauth; Katja de With; Maria Ruethrich; Catherina Lueck; Jacob Nattermann; Lene Tscharntke; Lisa Pilgram; Sandra Fuhrmann; Annika Classen; Melanie Stecher; Maximilian Schons Journal: Infection Date: 2020-10-01 Impact factor: 7.455
Authors: Destin Groff; Ashley Sun; Anna E Ssentongo; Djibril M Ba; Nicholas Parsons; Govinda R Poudel; Alain Lekoubou; John S Oh; Jessica E Ericson; Paddy Ssentongo; Vernon M Chinchilli Journal: JAMA Netw Open Date: 2021-10-01
Authors: Anna Solastie; Camilla Virta; Anu Haveri; Nina Ekström; Anu Kantele; Simo Miettinen; Johanna Lempainen; Pinja Jalkanen; Laura Kakkola; Timothée Dub; Ilkka Julkunen; Merit Melin Journal: Microbiol Spectr Date: 2021-11-17
Authors: Aziz Karaca; Mustafa Nuri Guncikan; Nazlı Nadire Sozmen; Gizem Gokce Karadag; Mustafa Yilmaz; Kerem Kinik; Fatma Meric Yilmaz Journal: Medeni Med J Date: 2021-09-30
Authors: Anna-Lena Mader; Leonid Tydykov; Vivian Glück; Manuela Bertok; Tanja Weidlich; Christine Gottwald; Alexa Stefl; Matthias Vogel; Annelie Plentz; Josef Köstler; Bernd Salzberger; Jürgen J Wenzel; Hans Helmut Niller; Jonathan Jantsch; Ralf Wagner; Barbara Schmidt; Thomas Glück; André Gessner; David Peterhoff Journal: iScience Date: 2022-03-14
Authors: Carolina Garrido; Jillian H Hurst; Cynthia G Lorang; Jhoanna N Aquino; Javier Rodriguez; Trevor S Pfeiffer; Tulika Singh; Eleanor C Semmes; Debra J Lugo; Alexandre T Rotta; Nicholas A Turner; Thomas W Burke; Micah T McClain; Elizabeth A Petzold; Sallie R Permar; M Anthony Moody; Christopher W Woods; Matthew S Kelly; Genevieve G Fouda Journal: JCI Insight Date: 2021-09-08